Literature DB >> 21880105

A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy.

Firas Abdollah1, Jan Schmitges, Maxine Sun, Shahrokh F Shariat, Alberto Briganti, Al'a Abdo, Zhe Tian, Paul Perrotte, Francesco Montorsi, Pierre I Karakiewicz.   

Abstract

OBJECTIVES: To examine the ability of the threshold recommended by the National Comprehensive Cancer Network (NCCN) in correctly predicting histologically-confirmed lymph node invasion (LNI). The 2010 NCCN practice guidelines for prostate cancer recommend a pelvic lymph node dissection (PLND) at radical prostatectomy in all individuals with a nomogram predicted LNI risk of ≥2%. PATIENTS AND METHODS: We assessed 20,877 patients who were treated with radical prostatectomy and PLND between 2004 and 2006, within the Surveillance, Epidemiology and End Results database. The 2% nomogram threshold, as well as other threshold values (range 1-10%) were tested. Finally, we externally validated the NCCN guideline nomogram.
RESULTS: Overall, 2.5% of patients had LNI. The use of the 2% threshold would allow the avoidance of 23% of PLNDs, at the cost of missing 1.7% of patients with LNI. Conversely, the use of a 3% threshold would allow the avoidance of 58% of PLNDs, at the cost of missing 15% of patients with LNI vs 72% and 26%, respectively, for the 4% threshold. Overall, the accuracy of the NCCN guideline nomogram quantified according to the receiver-operator characteristics-derived area under the curve was 82%.
CONCLUSIONS: In a population-based sample, the NCCN guideline nomogram is highly accurate. However, the 2% threshold will permit the avoidance of only 23% of PLNDs, instead of the 48% intended by the NCCN guidelines. The use of a 3% threshold may allow a lower rate of PLND overtreatment, although it will miss more patients with LNI.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21880105     DOI: 10.1111/j.1464-410X.2011.10518.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  3 in total

Review 1.  Prostate cancer nomograms: a review of their use in cancer detection and treatment.

Authors:  R J Caras; Joseph R Sterbis
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

Review 2.  Functional imaging for prostate cancer: therapeutic implications.

Authors:  Carina Mari Aparici; Youngho Seo
Journal:  Semin Nucl Med       Date:  2012-09       Impact factor: 4.446

3.  Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without Recurrence.

Authors:  Dae Keun Kim; Kyo Chul Koo; Ali Abdel Raheem; Ki Hong Kim; Byung Ha Chung; Young Deuk Choi; Koon Ho Rha
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.